The purpose of the NIMH Stem Cell Center is to provide a resource for postnatal-to-adult human control and patient-derived cells and their reprogrammed derivatives; this repository will support stem cell research relevant to mental disorders. This includes but is not limited to anxiety disorders, attention deficit hyperactivity disorder, autism spectrum disorders, bipolar disorder, borderline personality disorder, depression, eating disorders, obsessive-compulsive disorder, panic disorder, post-traumatic stress disorder, and schizophrenia. The capabilities of the repository will range from derivation and banking of primary source cells from postnatal through adult human subject tissue to more comprehensive banking and validation of iPSCs or similar reprogrammed/de-differentiated cells.
NIMH Center for Collaborative Studies of Mental Disorders at RUCDR
RUCDR is the National Institute of Mental Health (NIMH) Center for Collaborative Studies of Mental Disorders. We have established cell lines and DNA for this initiative since 1998. The NIMH collection now contains a vast array of samples from families with schizophrenia, bipolar disorder, Alzheimer's disease, autism, obsessive-compulsive disorder, depression, and ADHD. Many important discoveries have been made by investigators accessing these collections. There is a catalog listing cells available under the NIMH program.
The Center for Collaborative Genomic Studies on Mental Disorders is a collaboration of Rutgers University RUCDR, Washington University in St. Louis and the University of Southern California's Information Sciences Institute. It is funded by a grant from the National Institute of Mental Health.
NIH Center for Regenerative Medicine
RUCDR is the host for a collection of iPSC created by the NIH Center for Regenerative Medicine (CRM). There is a catalog of available lines. To inquire about ordering cells from the NIH CRM catalog, please use the contact form to request details.
Rutgers University Cell and DNA Repository (RUCDR) plays a key role in research aimed at understanding the genetic causes of common, complex diseases. RUCDR activities will enable gene discovery leading to diagnoses, treatments and, eventually, cures for these diseases. RUCDR assists researchers throughout the world by providing the highest quality biomaterials, technical consultation, and logistical support.